News-Wuhan Createrna Science and Technology Co.,Ltd.

Home
Scientific R&D
- Research Ability
- Pipeline
News Activity
- News Center
About Us
Join Us
- Careers
- Recruitment

CN

News Center

News

2023-09-28

Createrna Receives Capital Injection from Well-known Investment Institutions
2023-06-25

Createrna Announces Completion of Series A Financing at Its Strategic Investment Press Conference in Wuhan

2022-07-17

MY004567 tablets was approved by the FDA US. for clinical trials implied
2022-02-16

The application for clinical trial of MY008211A tablet was officially accepted by the State Food and Drug Administration
2021-08-11

MY004567 tablets was clinically approved by FDS
2020-11-04

Createrna was invited to participate in the Chinese Pharmaceutical Innovation Investment Forum

1